Valuation Gilead Sciences, Inc. Mexican S.E.

Stocks

End-of-day quote Mexican S.E. Other stock markets 10/06/2026			5-day change	1st Jan Change
2,117.15 ^MXN	-6.44%		0.00%	-4.73%

06-17	Gilead Sciences Insider Sold Shares Worth $376,200, According to a Recent SEC Filing	MT
06-16	Warsh Takes the Stage

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	91,081	107,677	100,942	115,118	152,281	155,755	-	-
Change	-	18.22%	-6.25%	14.04%	32.28%	2.28%	-	-
Enterprise Value (EV) ¹	118,530	126,522	118,665	131,838	169,585	165,323	155,659	145,348
Change	-	6.74%	-6.21%	11.1%	28.63%	-2.51%	-5.85%	-6.62%
P/E	14.7x	23.6x	18x	243x	18.1x	-44.9x	16.3x	14.9x
PBR	4.32x	5.05x	4.48x	5.98x	6.73x	8.52x	6.6x	5.24x
PEG	-	-0.9x	0.8x	-2.7x	0x	0x	-0x	1.63x
Capitalization / Revenue	3.34x	3.95x	3.72x	4x	5.17x	5.11x	4.8x	4.55x
EV / Revenue	4.34x	4.64x	4.38x	4.59x	5.76x	5.42x	4.8x	4.25x
EV / EBITDA	8.12x	8.86x	9.01x	11.7x	10.6x	29.9x	8.56x	7.6x
EV / EBIT	9.45x	10.4x	11.3x	15.5x	12.9x	60.4x	10x	8.74x
EV / FCF	11x	15.2x	16x	12.8x	17.9x	163x	11.8x	10.5x
FCF Yield	9.12%	6.59%	6.25%	7.82%	5.58%	0.62%	8.51%	9.57%
Dividend per Share ²	2.84	2.92	3	3.08	3.16	3.246	3.316	2.959
Rate of return	3.91%	3.4%	3.7%	3.33%	2.57%	2.59%	2.64%	2.36%
EPS ²	4.93	3.64	4.5	0.38	6.78	-2.791	7.7	8.404
Distribution rate	57.6%	80.2%	66.7%	811%	46.6%	-116%	43.1%	35.2%
Net sales ¹	27,305	27,281	27,116	28,754	29,443	30,478	32,450	34,218
EBITDA ¹	14,598	14,283	13,177	11,287	15,953	5,525	18,175	19,128
EBIT ¹	12,548	12,180	10,484	8,520	13,193	2,738	15,538	16,633
Net income ¹	6,225	4,592	5,665	480	8,510	-3,373	9,603	10,404
Net Debt ¹	27,449	18,845	17,723	16,720	17,304	9,568	-96.43	-10,407
Reference price ²	72.61	85.85	81.01	92.37	122.74	125.45	125.45	125.45
Nbr of stocks (in thousands)	1,254,384	1,254,244	1,246,042	1,246,266	1,240,680	1,241,570	-	-
Announcement Date	01/02/22	02/02/23	06/02/24	11/02/25	10/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	32.54x	11.83x	24.36x	0.61%	992B
JOHNSON & JOHNSON	25.03x	5.77x	15.69x	2.28%	564B
ABBVIE INC.	27.45x	6.62x	13.53x	3.1%	391B
ROCHE HOLDING AG	17.47x	4.34x	10.68x	3.06%	330B
ASTRAZENECA PLC	22.62x	4.72x	13.39x	1.85%	280B
NOVARTIS AG	21.12x	5.46x	13.25x	2.94%	279B
NOVO NORDISK A/S	12.67x	4.72x	9.72x	3.98%	196B
AMGEN INC.	22.21x	5.97x	10.43x	2.95%	184B
PFIZER INC.	12.12x	3.18x	7.73x	6.76%	148B
Average	21.47x	5.85x	13.20x	3.06%	373.69B
Weighted average by Cap.	24.82x	7.24x	16.13x	2.31%